# Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis

> **NCT05355207** · PHASE1 · UNKNOWN · sponsor: **Trellis Bioscience LLC** · enrollment: 12 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** TRL1068

## Key facts

- **NCT ID:** NCT05355207
- **Lead sponsor:** Trellis Bioscience LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355207, "Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05355207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*